CANVIREX
CanVirex is a developer of novel immunotherapeutics for the treatment of cancer.
CANVIREX
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2017-01-01
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Website Url:
http://www.canvirex.com
Total Employee:
1+
Status:
Active
Contact:
+41 61 515 0775
Current Employees Featured
Founder
Official Site Inspections
http://www.canvirex.com
- Host name: 233.254.214.35.bc.googleusercontent.com
- IP address: 35.214.254.233
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "CanVirex"
CanVirex - Crunchbase Company Profile & Funding
Organization. CanVirex . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. CanVirex is a …See details»
About CanVirex
CanVirex is a spin-off from the Heidelberg University Hospital, founded in 2017 in Basel, Switzerland. The company develops novel immunotherapeutics for the …See details»
CanVirex AG – Swiss Biotech
CanVirex is a next generation immunotherapeutics company founded as a spin-off from Heidelberg University Hospital and National Center for Tumor …See details»
CanVirex: Contact Details and Business Profile - RocketReach
CanVirex has also forged strategic collaborations with key industry partners for GMP manufacturing and commercialization of our products. CanVirex collaborates with the DZIF …See details»
CanVirex 2025 Company Profile: Valuation, Funding
CanVirex General Information Description. Developer of novel immunotherapeutics designed to improve the treatment of cancer and other viruses. The company provides a measles vector-based platform that …See details»
CanVirex AG - VentureRadar
CanVirex’s measles vector-based platform represents a highly promising technology for cancer immunotherapy and vaccine development against infectious diseases, e.g. COVID-19. Our …See details»
CanVirex - Contacts, Employees, Board Members, Advisors & Alumni
CanVirex is a developer of novel immunotherapeutics for the treatment of cancer. New. Resources. Advanced Search ... Experience the new Crunchbase, powered by AI . Experience …See details»
Team - CanVirex
At the core, CanVirex consists of a complementary team of experts with wide-reaching strengths and competencies. Bound together by trustworthiness and a common vision, each team …See details»
CanVirex - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Jan 13, 2025 CanVirex is a developer of novel immunotherapeutics for the treatment of cancer. New. Resources. Advanced Search. Start Free Trial . Talk With Sales ... Experience the new …See details»
CanVirex - Overview, News & Similar companies | ZoomInfo.com
Who is CanVirex. The company develops novel immunotherapeutics for the treatment of cancer and has recently committed to using its unique technology to develop a va ccination for …See details»
CanVirex - Products, Competitors, Financials, Employees, …
CanVirex is a biotechnology company focused on developing immunotherapeutics and vaccines using its proprietary oncolytic measles virus-vectored platform. The company specializes in …See details»
Investor Portal - CanVirex
All intelligent investing is value investing – acquiring more than you are paying for. Charlie Munger Investor Portal What we offer Reasons to invest Addressing areas of high unmet medical …See details»
CanVirex AG at the Swiss Biotech Day
CanVirex is a privately-owned, Swiss immuno-viro-therapeutics company with headquarters in Basel. The company develops a versatile platform for novel cancer therapies based on …See details»
Pipeline - CanVirex
Along with the strategic research alliance with the Heidelberg University Hospital, CanVirex constantly screens potential vector candidates that can be added to the existing portfolio. The …See details»
CanVirex - Crunchbase
CanVirex is a developer of novel immunotherapeutics for the treatment of cancer. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. …See details»
IDT Biologika Collaborates with CanVirex to Push Forward the …
Mar 6, 2023 Basel (Switzerland) and Dessau-Rosslau (Germany), Rockville, MD (USA), March 6th, 2023 – IDT Biologika, a leading Contract Development and Manufacturing Organization …See details»
CanVirex AG - VentureRadar
CanVirex’s measles vector-based platform represents a highly promising technology for cancer immunotherapy and vaccine development against infectious diseases, e.g. COVID-19. Our …See details»
IDT Biologika Collaborates with CanVirex to Push Forward the …
Mar 6, 2023 Biologika, a leading Contract Development and Manufacturing Organization (CDMO) specialized in vaccines, gene and immune therapy and oncolytic viruses, and …See details»
Technology - CanVirex
The science of today is the technology of tomorrow. Edward Teller Technology Measles vaccine vectors as transgene delivery platform Explore vector: Immuno-Oncology Vaccination Immuno …See details»